S. Koni Reddy's Insider Trades & SAST Disclosures
S. Koni Reddy's most recent trade in Concord Drugs Ltd. was a Acquisition of 25,000 Equity Shares done at an average price of Rs. 27.2 . Disclosure was reported to the exchange on Sept. 30, 2021 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
S. Koni Reddy's has made SAST transactions in Concord Drugs Ltd. recently where a Acquisition of 25,000 shares done . Disclosure was reported to the exchange on Sept. 30, 2021.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Concord Drugs | S. Koni Reddy | Promoter & Director | Acquisition | 30 Sep 2021 | 25,000 | 1,000,000 (11.44%) | 0.29% | 27.2 | 679,447 | 02 Sep 2021 28 Sep 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Concord Drugs | S Koni Reddy | Promoter | Acquisition | 01 Oct 2021 | 25,000 | 1,000,000 (11.44%) | 0.29% | - | 02 Sep 2021 28 Sep 2021 |
SAST (29(2)) | - | Market |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.